Three-day continuous glucose monitoring for rapid assessment of hypoglycemic events and glycemic variability in type 1 diabetic patients

Endocrine Journal

Volumn 58, Issue 7, 2011, Pages 535-541

  Kim, Soo Kyoung ^a   Suh, Sunghwan ^a   Kim, Mi Yeon ^a   Chung, Hye Soo ^a   Hur, Kyu Yeon ^a   Kim, Sun Wook ^a   Chung, Jae Hoon ^a   Lee, Myung Shik ^a   Min, Yong Ki ^a   Kim, Kwang Won ^a   Kim, Jae Hyeon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Continuous glucose monitoring system; Self monitoring of blood glucose; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC VARIABILITY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; RISK ASSESSMENT; SELF MONITORING;

ADULT; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; MALE; MONITORING, AMBULATORY; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 79961004377     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K10E-378     Document Type: Article

References (21)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J M 329:977-986.
2. Funnell MM, Brown TL, Childs BP, Haas LB, Hosey GM, Jensen B, Maryniuk M, Peyrot M, Piette JD, Reader D, Siminerio LM, Weinger K, Weiss (2010) National standards for diabetes self-management education. Diabetes Care Suppl 1:S89-96.
3. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV (2001) Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 24:1858-1862.
4. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young- Hyman D, Schlundt D, Clarke W (1998) Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 21:1870-1875.
5. Cryer PE, Fisher JN, Shamoon H (1994) Hypoglycemia. Diabetes Care 17:734-755.
6. Rodbard D (2009) New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 11:551-565.
7. The Diabetes Control and Complications Trial Research Group (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44:968-983.
8. Monnier L, Colette C (2008) Glycemic variability: should we and can we prevent it? Diabetes Care 31:S150-154.
9. Rodbard D (2009) Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 11:S55-67.
10. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W (2006) Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 29:2433-2438.
11. Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC (2004) Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 53:955-962.
12. Chico A, Vidal-Rios P, Subira M, Novials A (2003) The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 26:1153-1157.
13. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR (2010) Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study. Diabetes 59:1585-1590.
14. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19:644-655.
15. Hansen MV, Pedersen-Bjergaard U, Heller SR, Wallace TM, Rasmussen AK, Jørgensen HV, Pramming S, Thorsteinsson B (2009) Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract 85:183-188.
16. Miller ME, Bonds DE, Gerstein HC, Seaquist ER, Bergenstal RM, Calles-Escandon J, Childress RD, Craven TE, Cuddihy RM, Dailey G, Feinglos MN, Ismail-Beigi F, Largay JF, O'Connor PJ, Paul T, Savage PJ, Schubart UK, Sood A, Genuth S (2010) The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 340:b5444.
17. McCrimmon RJ, Frier BM (1994) Hypoglycaemia, the most feared complication of insulin therapy. Diabete Metab 20:503-512.
18. Hirsch IB, Brownlee M (2007) The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 30:186-187.
19. Kilpatrick ES, Rigby AS, Atkin SL (2006) The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 29:1486-1490.
20. Bragd J, Adamson U, Backlund LB, Lins PE, Moberg E, Oskarsson P (2008) Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab 34:612-616.
21. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681-1687.